XBiotech (XBIT) executive Simard sold 48,613 shares for $624K at an average $12.84
Insider transactions reported
John Simard (executive at XBiotech Inc., XBIT) reported that they sold 48,613 shares for $624K at an average $12.84 between Oct 4, 2021 and Oct 6, 2021. After these transactions the filing shows 3,962,452 shares held directly.
- Reporting person
- Simard John
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Oct 4, 2021 | Open-market sale (S) | Common Stock1 | -23,681 | $13.08 | $310K | 3,987,384 direct |
| Oct 5, 2021 | Open-market sale (S) | Common Stock1 | -14,218 | $12.66 | $180K | 3,973,166 direct |
| Oct 6, 2021 | Open-market sale (S) | Common Stock1 | -10,714 | $12.53 | $134K | 3,962,452 direct |
Holdings before and after
- Common Stock: 4,011,065 to 3,962,452 direct
Footnotes from the filing
- 1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide to XBIT, any security holder of XBIT, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
FAQ
What did Simard report in this XBIT Form 4?
John Simard (executive at XBiotech Inc., XBIT) reported that they sold 48,613 shares for $624K at an average $12.84 between Oct 4, 2021 and Oct 6, 2021. After these transactions the filing shows 3,962,452 shares held directly.
How many XBIT shares does Simard hold after this filing?
The filing shows 3,962,452 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this XBIT insider sale made under a 10b5-1 plan?
The filing's footnotes do not mention a Rule 10b5-1 trading plan.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for XBIT
Earlier insider filings at XBIT
- Oct 1, 2021SEC Form 4: Simard John sold $812,117 worth of shares (60,901 units at $13.34), decreasing direct ownership by 1% to 4,011,065 units
- Sep 28, 2021SEC Form 4: Simard John sold $753,419 worth of shares (51,200 units at $14.72), decreasing direct ownership by 1% to 4,071,966 units
- Sep 22, 2021SEC Form 4: Simard John sold $757,584 worth of Common Stock (50,000 units at $15.15), decreasing direct ownership by 1% to 4,123,166 units
- Jul 19, 2021SEC Form 4: SIMARD JOHN sold $907,350 worth of Common Stock (50,000 units at $18.15), decreasing direct ownership by 1% to 4,173,166 units
- Jul 12, 2021SEC Form 4: Libby Peter exercised 25,000 units of Common Shares at a strike of $7.76
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2015
Follow XBIT and get a push notification the moment its next story breaks.